2004, Número 2
<< Anterior Siguiente >>
Rev Mex Oftalmol 2004; 78 (2)
Nuevos e intrigantes conceptos en la oncogénesis del retinoblastoma. Análisis y revisión del tema
González-Almaraz G, Pineda-Cárdenas MAA, Garza-Ruíz E
Idioma: Español
Referencias bibliográficas: 105
Paginas: 57-70
Archivo PDF: 655.45 Kb.
RESUMEN
El retinoblastoma es una neoplasia maligna de la infancia, se origina en la retina y tiene un patrón hereditario bien definido autosómico dominante de penetración variable, puede asociarse a monosomías, translocaciones parciales, isocromosomas y mosaicismo. Las formas esporádicas pueden representar la forma inicial del rasgo familiar. En pacientes con formas hereditarias de la neoplasia y que sobreviven, se comprueba la posibilidad de desarrollar pinealomas y segundos tumores sin relación con la radiación, así como la acción de los sistemas de c-proto-oncogenes, anti-oncogenes y oncogenes relacionados con alteraciones en las proteínas supresoras que modifican los ciclos de proliferación celular.
El consejo genético esta en relación con la acción de los genes y juega un papel muy importante en el futuro de esta
neoplasia.
REFERENCIAS (EN ESTE ARTÍCULO)
González-Almaraz G, Pineda-Cárdenas MaAA. Retinoblastoma: Histopatología y su correlación clínica. Rev Med Hosp Gral Mex 1983; 46:10-24.
González-Almaraz G, De Buen S. Retinoblastoma. Algunas consideraciones clínico-patológicas. Trib Med 1975; 28(337): A3-A8.
González-Almaraz G. Consideraciones anatomopatológicas de la cirugía en el retinoblastoma. An Soc Mex Oftal 1976; 51:13-23.
Pineda-Cárdenas MaAA, González-Almaraz G. Aspectos metabólicos y bioquímicos del retinoblastoma. Rev Med Hosp Gral 1982; 45:50-54.
González-Almaraz G, Pineda-Cárdenas MaAA. Invasión al sistema nervioso central por el retinoblastoma. Bol Hosp Oftal Nta Sra Luz 1989; 41(143): 41-47.
González-Almaraz G, Pineda-Cárdenas MaAA, Rabinovitz KE. Retinoblastoma periférico (infiltrante difuso). Presentación de un caso. Rev Mex Oftalmol 1988; 62(1):1-6.
González-Almaraz G. Retinoblastoma: Invasión al Sistema Nervioso Central. Presentación de un caso. Rev Inst Nac Oftalmol 1988; 9(2):56-59.
Berkeley JS, Kalita BC. Retinoblastoma in an adult. Lancet 1977; 3:508-509.
Shields JA, Michelson JB, Leonard BC, Thompson R. Retinoblastoma in an Eighteen-years-old male. J Ped Ophthal 1975; 274-277.
Connolly MJ, Payne RH, Johnson G y cols. Familial, EsDlinked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 1983; 65:122-124.
Duane TB. Clinical Ophthalmology. Hagerstown: Harper and Row; 1980.
Gallie BL, Phillips RA. Multiple manifestations of the retinoblastoma gene. Birth Defects Orig Art Ser 1982; 18(6):689-701.
Gallie BL, Ellsworth RM, Abramson DM, Phillips RA. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Brit J Cancer 1982; 45: 513-521.
Brownstein S, de Chadarevian JP, Little JM. Trilateral retinoblastoma: report of two cases. Arch Ophthal 1984; 102:257-262.
Lueder GT, Judisch GF, Wen BC. Heritable retinoblastoma and pinealoma. Arch Ophthal 1991; 109:1707-1709.
Amoaku WMK, Willshaw HE, Parkes SE, Shah KJ, Mann JR. Trilateral retinoblastoma: a report of five patients. Cancer 196; 78:858-863.
Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma. J Clin Oncol 1999; 17:1829-1837.
Antillón F, Esponda JC. Sarcomas por irradiación de retinoblastomas. An Soc Mex Oftal 1977; 51:67-74.
Moll AC, Imhof SM, Schouten-Van Meeteren AYN y cols. Second primary tumors in hereditary retinoblastoma: a registerbased study, 1945-1997. Is there an age effect on radiationrelated risk? Ophthalmology 2001; 108:1109-1114.
Abramson DH, Ellsworth RM, Zimmerman LE. Monocular cancer in retinoblastoma survivors. Trans Am Acad Ophthal Otolaryng 1976; 81:454-457.
Francois J. Retinoblastoma and osteogenic sarcoma. Ophthalmologica 1977; 175:185-191.
Matsunaga E. Hereditary retinoblastoma: delayed mutation or host resistance? Am J Hum Genet 1978; 30:406-425.
Chauveinc L, Mosseri V, Quintana E y cols. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet 2001; 22:77-88.
Motegi T, Komatsu M, Minoda K. Is the interstitial deletion of 13q in retinoblastoma patients not transmissible? (Letter). Hum Genet 1983; 64:205.
Motegi T, Kaga M, Yanagawa Y y cols. A recognizable pattern of the midface of retinoblastoma patients with interstitial deletion of 13q. Hum Genet 1983; 64:160-162,
Fukushima Y, Kuroki Y, Ito T, Kondo I, Nishigaki I. Familial retinoblastoma (mother and son) with 13q14 deletion. Hum Genet 1987; 77:104-107.
Laquis SJ, Rodriguez-Galindo C, Wilson MW y cols. Retinoblastoma in a patient with an X;13 translocation and facial abnormalities consistent with 13q-syndrome. Am J Ophthal 2002; 133:285-287.
Bonaiti-Pellie C, Briard-Guillemot ML, Feingold J, Frezal J. Associated congenital malformations in retinoblastoma. Clin Genet 1975; 7:37-39.
Ejima Y, Sasaki MS, Kaneko A y cols. Possible inactivation of part of chromosome 13 due to 13qXp translocation associated with retinoblastoma. Clin Genet 1982; 21:357-361.
Friend SH, Bernards R, Rogelj S y cols. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323:643-646.
Friend SH, Dryja TP, Weinberg RA. Oncogenes and tumorsuppressing genes. New Eng J Med 1988; 318:618-622.
Friend SH, Horowitz JM, Gerber MR y cols. Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Nat Acad Sci. 1988; 85:2234.
Cance WG, Brennan MF, Dudas ME y cols. Altered expression of the retinoblastoma gene product in human sarcomas. New Eng J Med 1990; 323:1457-1462.
Gibbons B, Scott D, Hungerford JL, Cheung KL y cols. Retinoblastoma in association with the chromosome breakage syndromes Fanconi’s anaemia and Bloom’s syndrome: clinical and cytogenetic findings. Clin Genet 1995; 47:311-317.
Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997; 278:1043-1050.
Kivela T, Asko-Seljavaara S, Pihkala U, Hovi L, Heikkonen J. Sebaceous carcinoma of the eyelid associated with retinoblastoma. Ophthalmology 2001; 108:1124-1128.
González-Almaraz G, Pineda-Cárdenas Ma.A.A. Carcinoma sebáceo de los párpados (Carcinoma de Glándula de Meibomio) Correlación clínico-patológica. Rev Mex Oftalmol 1998; 72(4):157-173.
González-Almaraz G, Pineda-Cárdenas Ma.A.A. Carcinoma sebáceo. Rev Cent Dermatol Pascua 1999; 8 (2):76-85.
Brantley MA, Worley L, Harbour JW. Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy. Am J Ophthal 2002; 133:242-248.
Shields CL, Honavar S, Shields JA, Demirci H, Meadows AT. Vitrectomy in eyes with unsuspected retinoblastoma. Ophthalmology 2000; 107:2250-2255.
Honavar SG, Shields CL, Shields JA, Demirci H, Naduvilath TJ. Intraocular surgery after treatment of retinoblastoma. Arch Ophthal 2001; 119:1613-1621.
Honavar SG, Singh AD, Shields CL y cols. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthal 2002; 120:923-931.
Smith SM, Sorsby A. Retinoblastoma: some genetic aspects. Ann Hum Genet 1958; 23: 50-58.
Falls HF, Neel JV. Genetics of retinoblastoma. Arch Ophthal 1951; 46:367-389.
Knudson AG. Hereditary cancer, oncogenes and anti-oncogenes. Cancer Res 1985; 45:1437-1443.
Matsunaga,E. Almost synchronous appearance of bilateral retinoblastomas. (Letter) Am J Med Genet 1982; 11:485-487.
Fitzgerald PH, Stewart J, Suckling RD. Retinoblastoma mutation rate in New Zealand and support for the two-hit model. Hum Genet 1983; 64:128-130.
Dryja TP, Mukai S, Rapaport JM, Yandell DW. Parental origin of mutations of the retinoblastoma gene. (Abstract) Am J Hum Genet 1989; 45 (suppl.): A19.
Matsunaga E, Minoda K, Sasaki MS. Parental age and seasonal variation in the births of children with sporadic retinoblastoma: a mutation-epidemiologic study. Hum Genet 1990; 84:155-158.
DerKinderen DJ, Koten JW, Tan KEWP y cols. Parental age in sporadic hereditary retinoblastoma. Am J Ophthal 1990;. 110:605-609.
Macklin MT. Inheritance of retinoblastoma in Ohio. Arch Ophthal 1959; 62:842-851.
Connolly MJ, Payne RH, Johnson G y cols. Familial, EsDlinked, retinoblastoma with reduced penetrance and variable expressivity. Hum Genet 1983; 65:122-124.
Bundey S, Morten JEN. An unusual pedigree with retinoblastoma. Does it shed light on the delayed mutation and host resistance theories? Hum Genet 1981; 59:434-436.
Huang HJS, Yee JK, Shew JY y cols. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988; 242:1563-1566.
Scheffer H, Meerman GJ, Kruize YCM y cols. Linkage analysis of families with hereditary retinoblastoma: nonpenetrance of mutation, revealed by combined use of markers within and flanking the RB1 gene. Am J Hum Genet 1989; 45:252-260.
Dryja TP, Cavenee W, White R y cols. Homozygosity of chromosome 13 in retinoblastoma. New Eng J Med 1984; 310:550-553.
Munier FL, Wang MX, Spence MA y cols. Pseudo low penetrance in retinoblastoma: fortuitous familial aggregation of sporadic cases caused by independently derived mutations in two large pedigrees. Arch Ophthal 1993; 111:1507-1511.
Bia B, Cowell JK. Independent constitutional germline mutations occurring in the RB1 gene in cousins with bilateral retinoblastoma. Oncogene 1995; 11:977-979.
Schubert EL, Strong LC, Hansen MF. A splicing mutation in RB1 in low penetrance retinoblastoma. Hum Genet 1997; 100:557-563.
Stallard HB. The conservation treatment of retinoblastoma. Trans Ophthal 1962; 82:473.
Taylor AI. Dq-, Dr and retinoblastoma. Humangenetik 1970; 10:209-217.
Lele KP, Penrose LS, Stallard HB. Chromosome deletion in a case of retinoblastoma. Ann Hum Genet 1963; 27:171-174.
Gey W. Dq-, multiple Missbildungen und Retinoblastom. Humangenetik 1970; 10:362-365.
Orye E, Delbeke MJ, Vandenabeele B. Retinoblastoma and Dchromosome deletions. (Letter) Lancet 1971; II:1376.
Wilson MG, Towner JW, Fujimoto A. Retinoblastoma and Dchromosome deletions. Am J Hum Genet 1973; 25:57-61.
Grace E, Drennan J, Colver D, Gordon RR. The 13q deletion syndrome. J Med Genet 1971; 8:351-357.
Orye E, Delbeke MJ, Vandenabeele B. Retinoblastoma and long arm deletion of chromosome 13. Attempts to define the deleted segment. Clin Genet 1974; 5:457-464.
Francke U. Retinoblastoma and chromosome 13. Cytogenet Cell Genet 1976; 14:131-34.
Riccardi VM, Hittner HM, Francke U y cols. Partial triplication and deletion of 13q: study of a family presenting with bilateral retinoblastomas. Clin Genet 1979; 15:332-345.
Davison EV, Gibbons B, Aherne GES, Roberts DF. Chromosomes in retinoblastoma patients. Clin Genet 1979; 15:505-508.
Sparkes RS, Sparkes MC, Wilson MG y cols. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. (Abstract). Cytogenet Cell Genet 1979; 25:209.
Sparkes RS, Sparkes MC, Wilson MG y cols. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science 1980; 208:1042-1044.
Rivera H, Turleau C, de Grouchy J y cols. Retinoblastoma-del (13q14): report of two patients, one with a trisomic sib due to maternal insertion; gene-dosage effect for esterase D. Hum Genet 1981; 59:211-214.
Benedict WF,m Murphree AL, Banerjee A y cols. Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science 1983; 219:973-975.
Balaban-Malenbaum G, Gilbert F, Nichols WW y cols. A deleted chromosome no. 13 in human retinoblastoma cells: relevance to tumorigenesis. Cancer Genet Cytogenet 1981; 3:243-250.
Motegi T, Kaga M, Yanagawa Y y cols. A recognizable pattern of the midface of retinoblastoma patients with interstitial deletion of 13q. Hum Genet 1983; 64:160-162.
Ejima Y, Sasaki MS, Kaneko A, Tanooka H. Types, rates, origin and expressivity of chromosome mutations involving 13q14 in retinoblastoma patients. Hum Genet 1988; 79:118-123.
Shroeder WT, Chao LY, Dao DD y cols. Non random loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 1987; 40:413-420.
Lemieux N, Messier PE, Jacob JL, Milot J, Richer CL. Precise cytogenetic localization of the Rb locus at subband 13q14.11 by ultrastructural detection after immunochemical chromosome banding. (Abstract). Am J Hum Genet 1989; 45 (suppl.):A27.
Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997; 278:1043-1050.
Horsthemke B, Greger V, Barnert HJ, Hopping W, Passarge E. Detection of submicroscopic deletions and a DNA poly-morphism at the retinoblastoma locus. Hum Genet 1987; 76:257-261.
Lee WH, Shew JY, Hong FD y cols. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329:642-645.
Kimchi A, Wang XF, Weinberg RA, Cheifetz S, Massague J. Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells. Science 1988; 240:196-199.
Bogenmann E, Lochrie MA, Simon MI. Cone cell-specific genes expressed in retinoblastoma. Science 1988; 240:76-78.
Weichselbaum RR, Beckett M, Diamond A. Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. Proc Nat Acad Sci 1988; 85:2106-2109.
DeCaprio JA, Ludlow JW, Lynch D y cols. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58:1085-1095.
Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58:1097-1105.
Chen PL, Scully P, Shew JY, Wang JYJ, Lee WH. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58:1193-1198.
Hsieh JK, Chan FSG, O’Connor DJ y cols. RB regulates the stability and the apoptotic function of p53 via MDM2. Molec Cell 1999; 3:181-193.
Pennaneach V, Salles-Passador I, Munshi A y cols. The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner. Molec Cell 2001; 7:715-727.
Dahiya A, Wong S, Gonzalo S, Gavin M, Dean DC. Linking the Rb and Polycomb pathways. Molec Cell 2001; 8: 557-568.
Garcia-Cao M, Gonzalo S, Dean D, Blasco MA. A role for the Rb family of proteins in controlling telomere length. Nature Genet 2002;. 32:415-419.
Mukai N, Kobayashi S, Oguri M. Ultrastructural studies of human adneovirus-produced retinoblastoma-like neoplasms in Sprague-Dawley rats. Invest Ophthalmol 1974; 13(8): 593-601.
Albert DM, Reid TW. RNA-directed DNA_Polymerase activity in retinoblastoma: Report of its presence and possible significance. Amer J Ophthal 1973; 77:629-639.
González-Almaraz G, Pineda-Cárdenas MaAA, Villanueva-Diaz G. Retinoblastoma con Fleurettes (Diferenciación a fotorreceptores). Rev Mex Oftalmol 1987; 61(6): 279-286.
Chano T, Ikegawa S, Kontani K y cols. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 2002; 21:1295-1298.
Thomas DM, Carty SA, Piscopo DM y cols. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Molec Cell 2001; 8:303-316.
Naumova A, Sapienza C. The genetics of retinoblastoma, revisited. Am J Hum Genet 1994; 54:264-273.
Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature 1991; 353:83-86.
Otterson GW, Chen W, Coxon AB, Khleif SN, Kaye FJ. Incomplete penetrance of familial retinoblastoma linked to germline mutations that result in partial loss of RB function. Proc Nat Acad Sci. 1997; 94:12036-12040.
Macklin MT. A study of retinoblastoma in Ohio. Am J Hum Genet 1960; 12:1-43.
Jensen RD, Miller RW. Retinoblastoma: epidemiologic characteristics. New Eng J Med 1971; 285:307-311.
Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthal 1980; 98:1204-1210.
Sparkes RS, Sparkes MC, Wilson MG y cols. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. (Abstract). Cytogenet Cell Genet 1979; 25:209.
Sparkes RS, Sparkes MC, Wilson MG y cols. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science 1980; 208: 1042-1044.